Brief: Matinas Biopharma Announces Pricing Of Public Offering Of Common Stock
10/01/2020 13:40
Jan 10 (Reuters) - Matinas BioPharma Holdings Inc MTNB.A :
* MATINAS BIOPHARMA ANNOUNCES PRICING OF PUBLIC OFFERING OF
COMMON
STOCK
* MATINAS BIOPHARMA - PRICING OF PUBLIC OFFERING OF 32.3
MILLION
SHARES OF ITS COMMON STOCK, OFFERED AT A PRICE OF $1.55/SHARE
Source text for Eikon: ID:nGNX82mXgd
Further company coverage: MTNB.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Matinas BioPharma Holdings
See all newsBrief: GH Power Signs Multi-Year Hydrogen Offtake Agreement With Change Energy For Hamilton Facility Output
Brief: Gh Power And Tkms Continue To Explore Clean Energy Collaboration In Support Of Canada’S Future Patrol Submarine Project
Brief: Matinas Biopharma - Btig Terminates Sales Agreement With Matinas Biopharma Holdings, Effective Immediately On July 23, 2026 - SEC Filing
Brief: Matinas Biopharma Receives Notice Of Non-Compliance With NYSE American Continued Listing Standards And Acceptance Of Plan To Regain Compliance
Brief: Matinas Biopharma - May Offer Securities Up To $150 Million - SEC Filing